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Abstract-In microsomes of bovine adrenal medulla, there were two affinity binding sites for carbamylcholine with a high and a low affinity. Copper (1-10 / M) largely enhanced the affinity of carbamylcholine at the low affinity binding site, with a slight increase in the affinity at the high affinity binding site. On the other hand, copper slightly decreased the binding affinity of pirenzepine and atropine. Thus, low concentrations of copper modulate the muscarinic receptors in the adrenal medulla by selectively increasing agonist affinity.
Muscarinic receptors of mammalian tissues are tentatively classified into M1 and M2-subtypes, based on the respective high and low affinity for the nonclassical antagonist pirenzepine (1-4). M1 and M2 receptors can be modulated by transition metals (5-8) and guanine nucleotides (9), respectively. Recently, we found that bovine adrenal medulla possesses exclusively M1 receptors which exhibit a high affinity for pirenzepine and a minimal guanine regulation (10) . The present study was an attempt to examine the effect of copper on the binding property of adrenal medullary muscarinic receptors.
Adrenal medullary microsomes were pre pared from fresh bovine adrenal glands, as described previously (10) . Briefly, the adrenal medullary homogenate in 0.25 M sucrose containing 5 mM Tris/HCI (pH 7.5 at 25'C) was centrifuged at 1,000 x g for 10 min, at 22,600xg for 20 min and at 160,500xg for 30 min, consecutively. The final pellet (which contained purified micro somes) was washed once by suspending in ice-cold 50 mM Tris/HCI buffer (pH 7.4 at 37'C) and recentrifugation. The resultant pellet was suspended in the cold Tris/HCI buffer and used for the binding assays. Muscarinic receptor binding assays were performed according to the method described (10) , except for the use of 50 mM Tris/HCI buffer (pH 7.4 at 37'C) as an assay medium to avoid the production of CuCO3 or Cu3(PO4)2.
Saturation and drug compe tition experiments were done with 10-900 pM and 78.1 ±0.4 pM of /-(3H)quinuclidinyl benzilate (QNB; 33.2 Ci/ mmol, NEN), respectively.
All assays were done in duplicate.
Copper was added to the incu bation medium as CuCl2 at the final concen trations indicated. Specific binding of (3H) QN B was taken as the binding displaceable by 1 ,uM atropine. Protein was determined according to Lowry et al. (11) . Saturation and competition curves were analyzed by Scatchard transformation, log-probit analysis and a nonlinear least-squares curve fitting (LIGAN D with modification for the Apple II microcomputer), as described previously (10, 12, 13 (Fig. 1) . The IC50 value was decreased to 2.19 utM, indicating a 5.9-fold shift as compared with the control value ( Table 1 ). The nu value was increased to 0.57. In this case, there was a decrease in the K1 value from 1.73 ;PM to 0.36 ,iM, as well as a decrease in the K2 value to 26.1 ,tM. However, the shift of the K2 value (8.5-fold) was greater than that of the K1 value (4.8-fold). The population of the high affinity site (R1) was not sig nificantly changed in the presence of copper. The effect of copper was maximal at 10 ,tM, since the competition curve in the presence of 100 /tM copper (IC50=1.55±0.29 /tM, n"=0.59±0.03; n=3) extended over the curve with 10 tiM copper. These results indicate that low concentrations of copper increased the affinity of agonist binding to the ow affinity site, more selectively than that to the high affinity site.
On the other hand, copper (10 tiM) failed to alter the competition curves for pirenze pine and atropine. Computer-aided analysis of the curves indicated the presence of two affinity sites for pirenzepine, but revealed only a slight increase in K2 value (from 146 nM to 389 nM) by copper (Table 1) . No significant change was observed in the number of each affinity site. A slight increase in the K1 value by copper (from 0.29 nM to 0.39 nM) was also estimated with atropine (Table 1 ) . Thus, copper slightly decreased the binding affinity of antagonists.
Copper-induced alteration of muscarinic binding has been shown in the rat forebrain, where copper decreased the number of binding sites for (3H)QNB and increased the number of high affinity sites for acetylcholine and carbamylcholine (6, 7). Accordingly, the mode of action of copper was quite different between the adrenal medulla and rat forebrain, even though the muscarinic receptors in both tissues are mostly the M1 subtype.
The reason for the difference is unclear, but it might be due to the assay conditions used such as a different membrane preparation and assay medium. Alternatively, there may be a heterogeneity within M1 receptors. Further studies will be necessary to clarify the possibility. Nevertheless, our study clearly indicates that muscarinic receptors in bovine adrenal medulla can be modulated by low concentrations of copper through a highly selective increase in the agonist affinity toward the low affinity binding site. 
